Purpose of Review: This review aims to provide the basic knowledge on the genetics of hypokinetic and hyperkinetic movement disorders to guide clinicians in the decision of “who and what to test for?” Recent Findings: In recent years, the identification of various genetic causes of hypokinetic and hyperkinetic movement disorders has had a great impact on a better definition of different clinical syndromes. Indeed, the advent of next-generation sequencing (NGS) techniques has provided an impressive step forward in the easy identification of genetic forms. However, this increased availability of genetic testing has challenges, including the ethical issue of genetic testing in unaffected family members, “commercially” available home testing kits and the increasing number and relevance of “variants of unknown significance.” Summary: The emergent role of genetic factors has important implications on clinical practice and counseling. As a consequence, it is fundamental that practicing neurologists have a proper knowledge of the genetic background of the diseases and perform an accurate selection of who has to be tested and for which gene mutations.

Genetics of Movement Disorders and the Practicing Clinician; Who and What to Test for? / A. Di Fonzo, E. Monfrini, R. Erro. - In: CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS. - ISSN 1528-4042. - 18:7(2018 Jul), pp. 37.1-37.11. [10.1007/s11910-018-0847-1]

Genetics of Movement Disorders and the Practicing Clinician; Who and What to Test for?

E. Monfrini
Penultimo
;
2018

Abstract

Purpose of Review: This review aims to provide the basic knowledge on the genetics of hypokinetic and hyperkinetic movement disorders to guide clinicians in the decision of “who and what to test for?” Recent Findings: In recent years, the identification of various genetic causes of hypokinetic and hyperkinetic movement disorders has had a great impact on a better definition of different clinical syndromes. Indeed, the advent of next-generation sequencing (NGS) techniques has provided an impressive step forward in the easy identification of genetic forms. However, this increased availability of genetic testing has challenges, including the ethical issue of genetic testing in unaffected family members, “commercially” available home testing kits and the increasing number and relevance of “variants of unknown significance.” Summary: The emergent role of genetic factors has important implications on clinical practice and counseling. As a consequence, it is fundamental that practicing neurologists have a proper knowledge of the genetic background of the diseases and perform an accurate selection of who has to be tested and for which gene mutations.
Chorea; Dystonia; Genetics; Movement disorders; Next-generation sequencing; Parkinson’s disease;
Settore MED/26 - Neurologia
lug-2018
23-mag-2018
Article (author)
File in questo prodotto:
File Dimensione Formato  
s11910-018-0847-1.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 511.32 kB
Formato Adobe PDF
511.32 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1016488
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 19
social impact